🔴 SeaStar Medical is trading 10.72% down on October 14, 2026 with no confirmed company-specific catalyst

SeaStar Medical is trading at $3.21, down 10.72%, with no confirmed company-specific catalyst explaining the decline.

• The October 14 announcement concerned its chief medical officer receiving an award, not a clinical or regulatory development.
• The S&P 500 is down 0.61% and Nasdaq is down 0.84%, while healthcare is up 1.64%.
• The FDA breakthrough-device designation was announced October 7, not today.